Hosein Shahsavarani is the Principal Investigator of the Laboratory of Regenerative Medicine and Biomedical Innovations. His research interest involves Bone Tissue Engineering, human pluripotent stem cells (hPSCs), Genome Editing, and Lab-on-chip-directed differentiation. His research group focused on developing scalable platforms for highly controlled expansion and differentiation of stem cells, trans-differentiation, and using novel natural small molecules to regulate stem cell fate towards the production of functional and safe SC derivatives for regenerative medicine applications. His laboratory has also contributed to the development of new genetic strategies for studying mammalian pathways and exploiting patient-specific induced pluripotent stem (iPS) cells for disease modeling, biological systems modeling, drug discovery, and testing infectious diseases.
Hosein Shahsavarani is the Principal Investigator of the Laboratory of Regenerative Medicine and Biomedical Innovations. His research interest involves Bone Tissue Engineering, human pluripotent stem cells (hPSCs), Genome Editing, and Lab-on-chip-directed differentiation. His research group focused on developing scalable platforms for highly controlled expansion and differentiation of stem cells, trans-differentiation, and using novel natural small molecules to regulate stem cell fate towards the production of functional and safe SC derivatives for regenerative medicine applications. His laboratory has also contributed to the development of new genetic strategies for studying mammalian pathways and exploiting patient-specific induced pluripotent stem (iPS) cells for disease modeling, biological systems modeling, drug discovery, and testing infectious diseases.